Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025

April 2019 | 210 pages | ID: I6E661FF333EN
DPI Research

Abstracts

The global influenza vaccines market size is expected to surpass USD 6 billion by 2025.

“Influenza Vaccines Market: Global Industry Analysis, Share, Size, Growth, Opportunity and Forecast 2019-2025” presents an in-depth assessment of the global influenza vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global influenza vaccines market. The report includes historical data from 2013 to 2018 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global influenza vaccines market. The report also explores a detailed analysis of the number of persons being vaccinated with influenza vaccines globally from 2013 to 2018 and forecasts to 2025.

Additionally, the report includes assessment of clinical trials, promising influenza vaccines in the clinical development and rapid diagnostic testing for the management of influenza. It also provides a deep and thorough evaluation of the distribution channel and technique of the influenza vaccination. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores the detailed description of growth drivers and inhibitors of the global influenza vaccines market.

Further, prudent analysis has been done on the competitor’s part, where four major players grab a major share of the global influenza vaccine market by net sales. Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited) and AstraZeneca are the key influencers with their vaccines in the global influenza vaccines market. Other emerging players such as Novavax, Daiichi–Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd, Altimmune, FluGen, Moderna, Vaccitech, VaxInnate and BioDiem are making novel technology-based influenza vaccine which is likely to affect the market share during the forecast period.

The report concludes with the profiles of major players in the global influenza vaccines market. The key market players are evaluated on various parameters such as company overview, influenza vaccines portfolios, sales value analysis and recent development in the global influenza vaccines market.

The major and emerging companies dominating this market for its vaccines, services and continuous product developments are:

• Sanofi Pasteur
• GlaxoSmithKline (GSK)
• Seqirus (CSL Limited)
• AstraZeneca
• Mylan
• Sinovac Biotech Ltd.
• Gamma Vaccines Pty Ltd.
• Hualan Biological Engineering Inc.
• Shanghai Institute of Biological Products Co., Ltd.
• Novavax
• Daiichi–Sankyo
• Mitsubishi Tanabe Pharma
• BiondVax Pharmaceuticals Ltd
• Altimmune
• FluGen
• Moderna
• Vaccitech
• VaxInnate
• BioDiem

Twenty-One Major Markets (21MM) covered in the report are as follows:

• United States
• Canada
• Germany
• France
• Italy
• Spain
• United Kingdom
• Netherlands
• Sweden
• Denmark
• Poland
• Norway
• Finland
• Ireland
• Belgium
• Australia
• New Zealand
• Japan
• Brazil
• China
• India

The Latest Industry Data Included in this Report:

• Global Influenza Vaccines Market Size and Analysis (2013 – 2025)
• Global Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
• Global Influenza Vaccines Market Share Analysis and Forecast (2013 – 2025)
• Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast (2013 – 2025)
• Global Influenza Vaccines Market in Top 21 Countries and Forecast (2013 – 2025)
• Rapid Diagnostic Testing for the Management of Influenza
• Global Distribution Channel and Technique of Influenza Vaccination
• Promising Influenza Vaccines in Clinical Development
• Major Deals in the Global Influenza Vaccines Market
• Influenza Vaccines Clinical Trial Insights by Phase, Company & Country
• Market Definition for the Specified Topic Along with Identification of Key Drivers and Inhibitors for the Market
• A Comprehensive List of Key Market Players Along with the Analysis of their Current Vaccines Portfolios, Sales Value Analysis, and Recent Development

The Report Answers the Following Questions about the Global Influenza Vaccines Market:

• How has the global influenza vaccines market performed so far and how will it perform in the coming years?
• What are the key markets in the global influenza vaccines industry?
• How many numbers of persons being vaccinated with influenza vaccines globally during 2013 – 2025?
• What are the key drivers and inhibitors in the current market?
• What are the various influenza vaccines available globally?
• How is the market predicted to develop in the future?
• Who are the key players in this market space?

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES (2013 – 2025)

3. GLOBAL INFLUENZA VACCINES MARKET SIZE AND ANALYSIS (2013 – 2025)

4. GLOBAL INFLUENZA VACCINES MARKET SHARE ANALYSIS AND FORECAST (2013 – 2025)

4.1 Global Number of Persons Vaccinated with Influenza Vaccines Share and Forecast
4.2 Global Influenza Vaccines Market Share and Forecast

5. KEY DRIVERS AND INHIBITORS OF THE GLOBAL INFLUENZA VACCINES MARKET

5.1 Market Drivers
5.2 Market Inhibitors

6. GLOBAL INFLUENZA VACCINES MARKET IN TOP 21 COUNTRIES – GEOGRAPHICAL LANDSCAPE (VOLUME AND VALUE) (2013 – 2025)

6.1 United States
  6.1.1 United States Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.1.2 United States Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.2 Canada
  6.2.1 Canada Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.2.2 Canada Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.3 Germany
  6.3.1 Germany Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.3.2 Germany Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.4 France
  6.4.1 France Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.4.2 France Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.5 Italy
  6.5.1 Italy Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.5.2 Italy Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.6 Spain
  6.6.1 Spain Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.6.2 Spain Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.7 United Kingdom
  6.7.1 United Kingdom Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.7.2 United Kingdom Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.8 Netherlands
  6.8.1 Netherlands Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.8.2 Netherlands Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.9 Sweden
  6.9.1 Sweden Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.9.2 Sweden Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.10 Denmark
  6.10.1 Denmark Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.10.2 Denmark Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.11 Poland
  6.11.1 Poland Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.11.2 Poland Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.12 Norway
  6.12.1 Norway Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.12.2 Norway Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.13 Finland
  6.13.1 Finland Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.13.2 Finland Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.14 Ireland
  6.14.1 Ireland Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.14.2 Ireland Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.15 Belgium
  6.15.1 Belgium Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.15.2 Belgium Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.16 Australia
  6.16.1 Australia Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.16.2 Australia Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.17 New Zealand
  6.17.1 New Zealand Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.17.2 New Zealand Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.18 Japan
  6.18.1 Japan Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.18.2 Japan Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.19 Brazil
  6.19.1 Brazil Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.19.2 Brazil Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.20 China
  6.20.1 China Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.20.2 China Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.21 India
  6.21.1 India Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.21.2 India Influenza Vaccines Market Size & Analysis (2013 – 2025)
6.22 Other Countries
  6.22.1 Other Countries Number of Persons Vaccinated with Influenza Vaccines (2013 – 2025)
  6.22.2 Other Countries Influenza Vaccines Market Size & Analysis (2013 – 2025)

7. RAPID DIAGNOSTIC TESTING FOR THE MANAGEMENT OF INFLUENZA

8. GLOBAL DISTRIBUTION CHANNEL AND TECHNIQUE OF INFLUENZA VACCINATION

9. PROMISING INFLUENZA VACCINES IN CLINICAL DEVELOPMENT

10. MAJOR DEALS IN THE GLOBAL INFLUENZA VACCINES MARKET

10.1 Merger& Acquisitions
10.2 Collaboration Deal
10.3 Licensing Agreement
10.4 Exclusive Agreement
10.5 Distribution Agreement

11. INFLUENZA VACCINES CLINICAL TRIAL INSIGHTS BY PHASE, COMPANY & COUNTRY

11.1 Year 2018
11.2 Year 2017

12. KEY COMPANIES ANALYSIS

12.1 Sanofi Pasteur
  12.1.1 Business Overview
  12.1.2 Influenza Vaccines Portfolio
  12.1.3 Influenza Vaccine Value Sales Analysis
  12.1.4 Recent Development
12.2 GlaxoSmithKline (GSK)
  12.2.1 Business Overview
  12.2.2 Influenza Vaccines Portfolio
  12.2.3 Influenza Vaccine Sales Value Analysis
  12.2.4 Recent Development
12.3 Seqirus (CSL Limited)
  12.3.1 Business Overview
  12.3.2 Influenza Vaccines Portfolios
  12.3.3 Recent Development
12.4 AstraZeneca
  12.4.1 Business Overview
  12.4.2 Influenza Vaccines Portfolio
  12.4.3 Influenza Vaccine Sales Value Analysis
  12.4.4 Recent Development
12.5 Sinovac Biotech Ltd.
  12.5.1 Business Overview
  12.5.2 Influenza Vaccines Portfolio
  12.5.3 Influenza Vaccine Sales Value Analysis
  12.5.4 Recent Development
12.6 Gamma Vaccines Pty Ltd
  12.6.1 Business Overview
  12.6.2 Influenza Vaccines Portfolio
  12.6.3 Recent Development
12.7 Hualan Biological Engineering Inc
  12.7.1 Business Overview
  12.7.2 Influenza Vaccines Portfolio
  12.7.3 Recent Development
12.8 Shanghai Institute of Biological Products Co., Ltd.
  12.8.1 Business Overview
  12.8.2 Influenza Vaccine Portfolio
12.9 Mylan
  12.9.1 Business Overview
  12.9.2 Influenza Vaccine Portfolio
12.10 BioDiem
  12.10.1 Business Overview
  12.10.2 Influenza Vaccine Portfolio
  12.10.3 Recent Development

List Of Tables

LIST OF TABLES

Table 4–1: Global Number of Persons Vaccinated with Influenza Vaccines Share (Percent), 2013 – 2018
Table 4–2: Global Number of Persons Vaccinated with Influenza Vaccines Share Forecast (Percent), 2019 – 2025
Table 4–3: Global Influenza Vaccines Market Share (Percent), 2013 – 2018
Table 4–4: Global Influenza Vaccines Market Share Forecast (Percent), 2019 – 2025
Table 7–1: Influenza Virus Testing Methods
Table 8–1: Distribution of Influenza Vaccination
Table 9–1: Merger & Acquisitions in Influenza Vaccines Market (Million US$), 2003 – 2017
Table 9–2: Collaboration Deal in Influenza Vaccines Market, 2007 – 2018
Table 9–3: Licensing Agreement in Influenza Vaccines Market, 2007 – 2018
Table 9–4: Exclusive Agreement in Influenza Vaccines Market, 2009 – 2016
Table 9–5: Distribution Agreement in Influenza Vaccines Market, 2005 – 2016

List Of Figures

LIST OF FIGURES

Figure 2–1: Global Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 2–2: Global Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 3–1: Global Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 3–2: Global Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–1: United States Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–2: United States Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–3: United States Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–4: United States Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–5: Canada Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–6: Canada Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–7: Canada Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–8: Canada Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–9: Germany Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–10: Germany Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–11: Germany Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–12: Germany Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–13: France Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–14: France Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–15: France Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–16: France Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–17: Italy Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–18: Italy Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–19: Italy Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–20: Italy Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–21: Spain Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–22: Spain Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–23: Spain Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–24: Spain Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–25: United Kingdom Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–26: United Kingdom Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–27: United Kingdom Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–28: United Kingdom Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–29: Netherlands Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–30: Netherlands Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–31: Netherlands Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–32: Netherlands Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–33: Sweden Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–34: Sweden Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–35: Sweden Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–36: Sweden Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–37: Denmark Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–38: Denmark Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–39: Denmark Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–40: Denmark Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–41: Poland Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–42: Poland Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–43: Poland Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–44: Poland Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–45: Norway Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–46: Norway Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–47: Norway Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–48: Norway Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–49: Finland Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–50: Finland Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–51: Finland Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–52: Finland Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–53: Ireland Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–54: Ireland Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–55: Ireland Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–56: Ireland Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–57: Belgium Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–58: Belgium Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–59: Belgium Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–60: Belgium Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–61: Australia Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–62: Australia Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–63: Australia Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–64: Australia Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–65: New Zealand Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–66: New Zealand Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–67: New Zealand Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–68: New Zealand Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–69: Japan Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–70: Japan Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–71: Japan Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–72: Japan Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–73: Brazil Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–74: Brazil Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–75: Brazil Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–76: Brazil Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–77: China Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–78: China Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–79: China Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–80: China Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–81: India Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–82: India Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–83: India Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–84: India Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 6–85: Other Countries Number of Persons Vaccinated with Influenza Vaccines (Thousand), 2013 – 2018
Figure 6–86: Other Countries Number of Persons Vaccinated with Influenza Vaccines Forecast (Thousand), 2019 – 2025
Figure 6–87: Other Countries Influenza Vaccines Market (Million US$), 2013 – 2018
Figure 6–88: Other Countries Influenza Vaccines Market Forecast (Million US$), 2019 – 2025
Figure 8–1: Place of Influenza Vaccination for Children and Adults, 2017 – 2018
Figure 12–1: Sanofi Pasteur Influenza Vaccines Net Sales Value (Million US$), 2013 – 2018
Figure 12–2: Sanofi Pasteur Influenza Vaccines Net Sales Value Forecast (Million US$), 2019 – 2025
Figure 12–3: GSK Influenza Vaccines Net Sales Value (Million US$), 2013 – 2018
Figure 12–4: GSK Influenza Vaccines Net Sales Value Forecast (Million US$), 2019 – 2025
Figure 12–6: AstraZeneca Influenza Vaccines Net Sales Value (Million US$), 2013 – 2018